Cellectar Biosciences, Inc.
Doing business as (A Development Stage Company)
- UEI
- GG83LBASEK99
- CAGE
- 4BFM0
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- cellectar.com
- Founded
- 1996
- Employees
- 11-50
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| I-125-CLR1404 as a (NEO) adjuvant treatment option for triple-negative breast cancer | National Cancer Institute (NIH) | $2,292,085 |
Grant awards
Quick answers
Is Cellectar Biosciences, Inc. registered in SAM.gov?
Cellectar Biosciences, Inc.'s SAM.gov registration expired on April 20, 2026.
What is Cellectar Biosciences, Inc.'s most recent federal award?
Cellectar Biosciences, Inc.'s most recent federal grant award is A phase 1B, open-label, study of a novel targeted radiotherapy in children, adolescents and young adults with… (R44CA272070), from National Cancer Institute (NIH), on September 16, 2022.
On GovTribe
See Cellectar Biosciences, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors